A BILL 
To amend title IV of the Public Health Service Act to 
direct the Director of the National Institutes of Health, 
in consultation with the Director of the National Heart, 
Lung, and Blood Institute, shall establish a program 
under which the Director of the National Institutes of 
Health shall support or conduct research on valvular 
heart disease, and for other purposes. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
22:16 Apr 01, 2021
H1193
2 
•HR 1193 IH
SECTION 1. SHORT TITLE. 
1
This Act may be cited as the ‘‘Cardiovascular Ad-
2
vances in Research and Opportunities Legacy Act’’. 
3
SEC. 2. GRANTS FOR VALVULAR HEART DISEASE RE-
4
SEARCH. 
5
Subpart 2 of part C of title IV of the Public Health 
6
Service Act (42 U.S.C. 285b et seq.) is amended by insert-
7
ing after section 424C (42 U.S.C. 285b–7c) the following: 
8
‘‘SEC. 424D. GRANTS FOR VALVULAR HEART DISEASE RE-
9
SEARCH. 
10
‘‘(a) IN GENERAL.—The Director of the National In-
11
stitutes of Health, in consultation with the Director of the 
12
Institute, shall support or conduct research regarding val-
13
vular heart disease. 
14
‘‘(b) SUPPORT GUIDELINES.—The distribution of 
15
funding authorized in subsection (a) may be used to pur-
16
sue the following outcomes— 
17
‘‘(1) using precision medicine and advanced 
18
technological imaging to generate data on individ-
19
uals with valvular heart disease; 
20
‘‘(2) identifying and developing a cohort of indi-
21
viduals with valvular heart disease and available 
22
data; 
23
‘‘(3) corroborating data generated through clin-
24
ical trials to develop a prediction model to distin-
25
guish individuals at high risk for sudden cardiac ar-
26
22:16 Apr 01, 2021
H1193
3 
•HR 1193 IH
rest or sudden cardiac death from valvular heart dis-
1
ease; or 
2
‘‘(4) for other outcomes needed to acquire nec-
3
essary data on valvular heart disease. 
4
‘‘(c) MITRAL VALVE PROLAPSE WORKSHOP.—Not 
5
later than one year after the date of the enactment of this 
6
section, the Director of the Institute shall convene a work-
7
shop composed of subject matter experts and stakeholders 
8
to identify research needs and opportunities to develop 
9
prescriptive guidelines for treatment of individuals with 
10
mitral valve prolapse. 
11
‘‘(d) AUTHORIZATION OF APPROPRIATIONS.—For the 
12
purpose of carrying out this section, there is authorized 
13
to be appropriated $20,000,000 for each of fiscal years 
14
2022 through 2026.’’. 
15
SEC. 3. PROGRAMS OF CENTERS FOR DISEASE CONTROL 
16
AND PREVENTION. 
17
Part J of title III of the Public Health Service Act 
18
(42 U.S.C. 2 et seq.) is amended by inserting after section 
19
393 the following section: 
20
‘‘SEC. 393A. PREVENTION OF SUDDEN CARDIAC DEATH AS A 
21
RESULT OF VALVULAR HEART DISEASE. 
22
‘‘(a) IN GENERAL.—The Secretary, acting through 
23
the Director of the Centers for Disease Control and Pre-
24
vention, may carry out projects to increase education, 
25
22:16 Apr 01, 2021
H1193
4 
•HR 1193 IH
awareness or diagnosis of valvular heart disease and to 
1
reduce the incidence of sudden cardiac death caused by 
2
valvular heart disease. Such projects may be carried out 
3
by the Secretary directly or through awards of grants or 
4
contracts to public or nonprofit private entities. The Sec-
5
retary may directly (or through such awards) provide tech-
6
nical assistance with respect to the planning, development, 
7
and operation of such projects. 
8
‘‘(b) CERTAIN ACTIVITIES.—Projects carried out 
9
under subsection (a) may include— 
10
‘‘(1) the implementation of public information 
11
and education programs for— 
12
‘‘(A) the prevention of sudden cardiac 
13
death from valvular heart disease; 
14
‘‘(B) broadening the awareness of the pub-
15
lic concerning the risk factors for, the symp-
16
toms of, and the public health consequences of 
17
valvular heart disease; and 
18
‘‘(C) increasing screening, detection, and 
19
diagnosis of valvular heart disease; and 
20
‘‘(2) surveillance of out of hospital cardiac ar-
21
rests to improve patient outcomes. 
22
‘‘(c) GRANT PRIORITIZATION.—The Secretary may, 
23
in awarding grants or entering into contracts pursuant to 
24
subsection (a), give priority to entities seeking to carry 
25
22:16 Apr 01, 2021
H1193
5 
•HR 1193 IH
out projects that target populations most impacted by val-
1
vular heart disease. 
2
‘‘(d) COORDINATION OF ACTIVITIES.—The Secretary 
3
shall ensure that activities under this section are coordi-
4
nated, as appropriate, with other agencies of the Public 
5
Health Service that carry out activities regarding valvular 
6
heart disease. 
7
‘‘(e) BEST
PRACTICES.—The Secretary, acting 
8
through the Director of the Centers for Disease Control 
9
and Prevention, shall— 
10
‘‘(1) collect and analyze the findings of research 
11
conducted with respect to valvular heart disease; and 
12
‘‘(2) taking into account such findings, publish 
13
on the website of the Centers for Disease Control 
14
and Prevention best practices for physicians and 
15
other health care providers who provide care to indi-
16
viduals with valvular heart disease. 
17
‘‘(f) AUTHORIZATION OF APPROPRIATIONS.—For the 
18
purpose of carrying out this section, there is authorized 
19
to be appropriated such sums as may be necessary for 
20
each of fiscal years 2022 through 2026.’’. 
21
Æ 
22:16 Apr 01, 2021
H1193
